Maravai Lifesciences Holdings (MRVI) Liabilities from Discontinued Operations (2021)
Maravai Lifesciences Holdings' (MRVI) quarterly Liabilities from Discontinued Operations came in at 11487000.0 in Q2 2021.
Maravai Lifesciences Holdings (MRVI) Liabilities from Discontinued Operations (2021) Analysis & Trends
Maravai Lifesciences Holdings' Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 11487000.0 for Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 11.49 Mn |
| Jun 30, 2021 | 11.49 Mn |